中国麻风皮肤病杂志 ›› 2025, Vol. 41 ›› Issue (10): 750-752.doi: 10.12144/zgmfskin202510750

• 病例报告 • 上一篇    下一篇

乌帕替尼治疗激素依赖性皮炎一例

朱婷婷1,2,3,4,黄鹤群1,2,3,4,马铜川1,2,3,4,朱月影1,2,3,4,肖风丽1,2,3,4   

  1. 1安徽医科大学第一附属医院皮肤科,安徽合肥,230032; 2安徽医科大学皮肤病研究所,安徽合肥,230032; 3皮肤病学教育部重点实验室,安徽医科大学,安徽合肥,230032; 4疑难重症皮肤病协同创新中心,安徽医科大学,安徽合肥,230032
  • 出版日期:2025-10-15 发布日期:2025-09-29

Upadacitinib in the treatment of steroid-dependent dermatitis: a case report

ZHU Tingting1,2,3,4, HUANG Hequn1,2,3,4, MA Tongchuan1,2,3,4, ZHU Yueying1,2,3,4, XIAO Fengli1,2,3,4   

  1. 1 Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei 230032, China; 2 Institute of Dermatology, Anhui Medical University, Hefei 230032, China; 3 Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230032, China; 4 Collaborative Innovation Center of Complex and Severe Skin Disease, Anhui Medical University, Hefei 230032, China
  • Online:2025-10-15 Published:2025-09-29

摘要: 激素依赖性皮炎是一种慢性复发性皮肤病,主要由于长期不当外用皮质类固醇所致,常见于面部。本例患者因面部红斑、瘙痒反复发作1年,诊断为激素依赖性皮炎。多种治疗无效后,使用乌帕替尼15 mg/d口服,治疗4周,症状显著改善,8周完全缓解,无不良反应。

关键词: 激素依赖性皮炎, JAK抑制剂, 乌帕替尼

Abstract: Steroid-dependent dermatitis is a chronic, recurrent skin condition primarily caused by the prolonged improper use of topical corticosteroids, commonly occurring on the face. In this case, the patient had recurrent facial erythema and itching for 1 year and was diagnosed with steroid-dependent dermatitis. After multiple treatments failed, oral upadacitinib 15 mg/d was administered, and after 4 weeks of treatment, the symptoms significantly improved. Complete resolution was achieved after 8 weeks, with no adverse reactions.

Key words: steroid-induced dermatitis, JAK inhibitor, upadacitinib